• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

终末期肾病中的胃肠疾病

Gastrointestinal disease in end-stage renal disease.

作者信息

Khan Ayesha, Mushtaq Muhammad, Movva Giri, Sohal Aalam, Yang Juliana

机构信息

Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX 77550, United States.

Gastroenterology and Hepatology, Creighton University School of Medicine, Phoenix, AZ 85012, United States.

出版信息

World J Nephrol. 2025 Mar 25;14(1):101917. doi: 10.5527/wjn.v14.i1.101917.

DOI:10.5527/wjn.v14.i1.101917
PMID:40134640
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11755235/
Abstract

When kidney function declines to a point where it can no longer maintain life and requires renal replacement therapy ( renal transplant or dialysis), it is called end-stage renal disease (ESRD). Patients with ESRD often experience a range of gastrointestinal (GI) symptoms, with prevalence rates reported as high as 77%-79%. These symptoms and pathologies arise from various factors, including electrolyte imbalance, fluid imbalance, toxin buildup, uremia, medications, dietary and lifestyle restrictions, and the effects of dialysis. GI diseases in patients with renal failure can be further categorized into upper GI, small bowel, and lower GI issues. Common conditions include gastroesophageal reflux disease, nausea and vomiting, dysmotility within the esophagus and stomach, upper GI bleeding, peptic ulcer bleeding, angioectasia, irritable bowel syndrome, mesenteric ischemia, angiodysplasia, diverticular disease, constipation, pancreatitis, and diseases associated with peritoneal dialysis peritonitis and peritoneal stenosis. This review assesses the existing literature on the different GI diseases among individuals with ESRD, shedding light on their pathophysiology and prevalence.

摘要

当肾功能下降到无法维持生命的程度,需要进行肾脏替代治疗(肾移植或透析)时,就称为终末期肾病(ESRD)。ESRD患者常出现一系列胃肠道(GI)症状,报告的患病率高达77%-79%。这些症状和病理状况由多种因素引起,包括电解质失衡、液体失衡、毒素蓄积、尿毒症、药物、饮食和生活方式限制以及透析的影响。肾衰竭患者的胃肠道疾病可进一步分为上消化道、小肠和下消化道问题。常见病症包括胃食管反流病、恶心和呕吐、食管和胃动力障碍、上消化道出血、消化性溃疡出血、血管扩张、肠易激综合征、肠系膜缺血、血管发育异常、憩室病、便秘、胰腺炎以及与腹膜透析相关的腹膜炎和腹膜狭窄等疾病。本综述评估了关于ESRD患者中不同胃肠道疾病的现有文献,阐明了其病理生理学和患病率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7852/11755235/ccc2fd1d12b6/101917-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7852/11755235/2bc291684c0e/101917-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7852/11755235/9bdc2c6583ce/101917-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7852/11755235/65836ea3d4b3/101917-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7852/11755235/ccc2fd1d12b6/101917-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7852/11755235/2bc291684c0e/101917-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7852/11755235/9bdc2c6583ce/101917-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7852/11755235/65836ea3d4b3/101917-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7852/11755235/ccc2fd1d12b6/101917-g004.jpg

相似文献

1
Gastrointestinal disease in end-stage renal disease.终末期肾病中的胃肠疾病
World J Nephrol. 2025 Mar 25;14(1):101917. doi: 10.5527/wjn.v14.i1.101917.
2
Gastroesophageal reflux disease in chronic renal failure patients with upper GI symptoms: multivariate analysis of pathogenetic factors.慢性肾功能衰竭患者出现上消化道症状时的胃食管反流病:致病因素的多变量分析
Am J Gastroenterol. 2002 Jun;97(6):1352-6. doi: 10.1111/j.1572-0241.2002.05772.x.
3
Different Risk of Common Gastrointestinal Disease Between Groups Undergoing Hemodialysis or Peritoneal Dialysis or With Non-End Stage Renal Disease: A Nationwide Population-Based Cohort Study.血液透析、腹膜透析或非终末期肾病患者群体中常见胃肠疾病的不同风险:一项基于全国人口的队列研究
Medicine (Baltimore). 2015 Sep;94(36):e1482. doi: 10.1097/MD.0000000000001482.
4
Prevalence of gastrointestinal and psychosomatic symptoms among Asian patients undergoing regular hemodialysis.亚洲接受常规血液透析患者的胃肠道和躯体症状患病率。
Nephrology (Carlton). 2013 Feb;18(2):97-103. doi: 10.1111/nep.12000.
5
Range and consistency of gastrointestinal outcomes reported in peritoneal dialysis trials: A systematic review.腹膜透析试验中报告的胃肠道结局的范围和一致性:系统评价。
Perit Dial Int. 2023 Jul;43(4):315-323. doi: 10.1177/08968608221126849. Epub 2022 Sep 20.
6
Gastric electrical stimulation: an evidence-based analysis.胃电刺激:基于证据的分析。
Ont Health Technol Assess Ser. 2006;6(16):1-79. Epub 2006 Aug 1.
7
Colonic Mucosal Ulceration and Gastrointestinal Bleeding Associated with Sevelamer Crystal Deposition in a Patient with End Stage Renal Disease.终末期肾病患者中与司维拉姆晶体沉积相关的结肠黏膜溃疡和胃肠道出血
Case Rep Nephrol. 2018 Feb 28;2018:4708068. doi: 10.1155/2018/4708068. eCollection 2018.
8
Gastrointestinal Disorders in Peritoneal Dialysis Patients.腹膜透析患者的胃肠道紊乱。
Am J Nephrol. 2018;48(5):319-325. doi: 10.1159/000494145. Epub 2018 Oct 19.
9
Gastrointestinal dysmotility disorders in critically ill dogs and cats.危重病犬猫的胃肠动力障碍
J Vet Emerg Crit Care (San Antonio). 2016 Mar-Apr;26(2):234-53. doi: 10.1111/vec.12449. Epub 2016 Jan 28.
10
Gastrointestinal symptoms: a comparison between patients undergoing peritoneal dialysis and hemodialysis.胃肠道症状:腹膜透析患者与血液透析患者的比较
World J Gastroenterol. 2014 Aug 28;20(32):11370-5. doi: 10.3748/wjg.v20.i32.11370.

本文引用的文献

1
Association between Proton Pump Inhibitor Use and Risk of Incident Chronic Kidney Disease: Systematic Review and Meta-Analysis.质子泵抑制剂的使用与新发慢性肾脏病风险之间的关联:系统评价与荟萃分析
Biomedicines. 2024 Jun 25;12(7):1414. doi: 10.3390/biomedicines12071414.
2
Standard of Care Versus Octreotide in Angiodysplasia-Related Bleeding (the OCEAN Study): A Multicenter Randomized Controlled Trial.标准治疗与奥曲肽在血管发育不良相关出血中的对比(OCEAN 研究):一项多中心随机对照试验。
Gastroenterology. 2024 Apr;166(4):690-703. doi: 10.1053/j.gastro.2023.12.020. Epub 2023 Dec 28.
3
Gastrointestinal bleeding in chronic kidney disease patients: a systematic review and meta-analysis.
慢性肾脏病患者的胃肠道出血:系统评价和荟萃分析。
Ren Fail. 2023;45(2):2276908. doi: 10.1080/0886022X.2023.2276908. Epub 2023 Nov 13.
4
Thalidomide for Recurrent Bleeding Due to Small-Intestinal Angiodysplasia.沙利度胺治疗小肠血管发育不良所致反复出血
N Engl J Med. 2023 Nov 2;389(18):1649-1659. doi: 10.1056/NEJMoa2303706.
5
Updates on Infectious and Other Complications in Peritoneal Dialysis: Core Curriculum 2023.腹膜透析相关感染及其他并发症更新:2023 年核心课程。
Am J Kidney Dis. 2023 Oct;82(4):481-490. doi: 10.1053/j.ajkd.2023.03.011. Epub 2023 Jul 12.
6
The Relationship between Gastroesophageal Reflux Disease and Chronic Kidney Disease.胃食管反流病与慢性肾脏病之间的关系
J Pers Med. 2023 May 13;13(5):827. doi: 10.3390/jpm13050827.
7
Outcomes of Acute Mesenteric Ischemia in End-Stage Renal Disease and Predictors of Mortality: A Nationwide Assessment.终末期肾病患者急性肠系膜缺血的结局及死亡率预测因素:一项全国性评估
Cureus. 2023 Apr 16;15(4):e37657. doi: 10.7759/cureus.37657. eCollection 2023 Apr.
8
Characteristics and outcomes of hospital-acquired and community-acquired peritonitis in patients on peritoneal dialysis: a retrospective cohort study.在腹膜透析患者中,医院获得性和社区获得性腹膜炎的特征和结局:一项回顾性队列研究。
J Nephrol. 2023 Sep;36(7):1877-1888. doi: 10.1007/s40620-023-01597-w. Epub 2023 Mar 13.
9
Comparison of Gastrointestinal Symptoms between Patients Undergoing Hemodialysis and Healthy Population.血液透析患者与健康人群胃肠道症状的比较
Middle East J Dig Dis. 2022 Jul;14(3):310-316. doi: 10.34172/mejdd.2022.288. Epub 2022 Jul 30.
10
Peritoneal Dialysis Prescription and Adequacy in Clinical Practice: Core Curriculum 2023.临床实践中的腹膜透析处方与充分性:2023年核心课程
Am J Kidney Dis. 2023 Jan;81(1):100-109. doi: 10.1053/j.ajkd.2022.07.004. Epub 2022 Oct 5.